|
1
|
Chang S, Dai M, Ren JS, Chen YH and Guo
LW: Estimates and prediction on incidence, mortality and prevalence
of lung cancer in China in 2008. Zhonghua Liu Xing Bing Xue Za Zhi.
33:391–394. 2012.(In Chinese). PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. In J Cancer. 127:2893–2917. 2010.
|
|
3
|
Fitzgibbons PL and Kern WH: Adenosquamous
carcinoma of the lung: A clinical and pathologic study of seven
cases. Hum Pathol. 16:463–466. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ishida T, Kaneko S, Yokoyama H, Inoue T,
Sugio K and Sugimachi K: Adenosquamous carcinoma of the lung.
Clinicopathologic and immunohistochemical features. Am J Clin
Pathol. 97:678–685. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shimizu J, Oda M, Hayashi Y, Nonomura A
and Watanabe Y: A clinicopathologic study of resected cases of
adenosquamous carcinoma of the lung. Chest. 109:989–994. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gibbs AR and Thunnissen FB: Histological
typing of lung and pleural tumours: Third edition. J Clin Pathol.
54:498–499. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sridhar KS, Bounassi MJ, Raub W Jr and
Richman SP: Clinical features of adenosquamous lung carcinoma in
127 patients. Am Rev Respir Dis. 142:19–23. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee Y, Chung JH, Kim SE, Kim TJ and Lee
KW: Adenosquamous carcinoma of the lung: CT, FDG PET, and
clinicopathologic findings. Clin Nucl Med. 39:107–112.
2014.PubMed/NCBI
|
|
9
|
Maeda H, Matsumura A, Kawabata T, Suito T,
Kawashima O, Watanabe T, Okabayashi K and Kubota I: Japan National
Hospital Organization Study Group for Lung Cancer: Adenosquamous
carcinoma of the lung: Surgical results as compared with squamous
cell and adenocarcinoma cases. Eur J Cardiothorac Surg. 41:357–361.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mordant P, Grand B, Cazes A, Foucault C,
Dujon A, Le Pimpec Barthes F and Riquet M: Adenosquamous carcinoma
of the lung: Surgical management, pathologic characteristics, and
prognostic implications. Ann Thorac Surg. 95:1189–1195. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ji Y, Sheng L, Du X, Qiu G and Su D:
Elevated platelet count is a strong predictor of poor prognosis in
stage I non-small cell lung cancer patients. Platelets. 26:138–142.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang HG, Li J, Shi SB, Chen P, Ge LP,
Jiang Q and Tang XP: Value of fibrinogen and D-dimer in predicting
recurrence and metastasis after radical surgery for non-small cell
lung cancer. Med Oncol. 31:222014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim KH, Park TY, Lee JY, Lee SM, Yim JJ,
Yoo CG, Kim YW, Han SK and Yang SC: Prognostic significance of
initial platelet counts and fibrinogen level in advanced non-small
cell lung cancer. J Korean Med Sci. 29:507–511. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kos M, Hocazade C, Kos FT, Uncu D, Karakas
E, Dogan M, Uncu HG, Yildirim N and Zengin N: Prognostic role of
pretreatment platelet/lymphocyte ratio in patients with non-small
cell lung cancer. Wien Klin Wochenschr. 128:635–640. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kwon HC, Kim SH, Oh SY, Lee S and Lee JH,
Choi HJ, Park KJ, Roh MS, Kim SG, Kim HJ and Lee JH: Clinical
significance of preoperative neutrophil-lymphocyte versus
platelet-lymphocyte ratio in patients with operable colorectal
cancer. Biomarkers. 17:216–222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pinato DJ, Shiner RJ, Seckl MJ, Stebbing
J, Sharma R and Mauri FA: Prognostic performance of
inflammation-based prognostic indices in primary operable non-small
cell lung cancer. Br J Cancer. 110:1930–1935. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sheng L, Luo M, Sun X, Lin N, Mao W and Su
D: Serum fibrinogen is an independent prognostic factor in operable
nonsmall cell lung cancer. Int J Cancer. 133:2720–2725.
2013.PubMed/NCBI
|
|
20
|
Yao Y, Yuan D, Liu H, Gu X and Song Y:
Pretreatment neutrophil to lymphocyte ratio is associated with
response to therapy and prognosis of advanced non-small cell lung
cancer patients treated with first-line platinum-based
chemotherapy. Cancer Immunol Immunother. 62:471–479. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu D, Liu B, Zhang L and Du K: Platelet
count predicts prognosis in operable non-small cell lung cancer.
Exp Ther Med. 5:1351–1354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu JF, Cai L, Zhang XW, Wen YS, Su XD,
Rong TH and Zhang LJ: High plasma fibrinogen concentration and
platelet count unfavorably impact survival in non-small cell lung
cancer patients with brain metastases. Chin J Cancer. 33:96–104.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Unal D, Eroglu C, Kurtul N, Oguz A and
Tasdemir A: Are neutrophil/lymphocyte and platelet/lymphocyte rates
in patients with non-small cell lung cancer associated with
treatment response and prognosis? Asian Pac J Cancer Prev.
14:5237–5242. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vallières E, Shepherd FA, Crowley J, Van
Houtte P, Postmus PE, Carney D, Chansky K, Shaikh Z and Goldstraw
P: International Association for the Study of Lung Cancer
International Staging Committee and Participating Institutions: The
IASLC Lung Cancer Staging Project: Proposals regarding the
relevance of TNM in the pathologic staging of small cell lung
cancer in the forthcoming (seventh) edition of the TNM
classification for lung cancer. J Thorac Oncol. 4:1049–1059. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dubernard V, Arbeille BB, Lemesle MB and
Legrand C: Evidence for an alpha-granular pool of the cytoskeletal
protein alpha-actinin in human platelets that redistributes with
the adhesive glycoprotein thrombospondin-1 during the exocytotic
process. Arterioscler Thromb Vasc Biol. 17:2293–2305. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kaplan KL, Broekman MJ, Chernoff A,
Lesznik GR and Drillings M: Platelet alpha-granule proteins:
Studies on release and subcellular localization. Blood. 53:604–618.
1979.PubMed/NCBI
|
|
27
|
Qian X and Tuszynski GP: Expression of
thrombospondin-1 in cancer: A role in tumor progression. Proc Soc
Exp Biol Med. 212:199–207. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng S, Shen J, Jiao Y, Liu Y, Zhang C,
Wei M, Hao S and Zeng X: Platelets and fibrinogen facilitate each
other in protecting tumor cells from natural killer cytotoxicity.
Cancer Sci. 100:859–865. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Huang SH, Li H, Li Y, Chen XL,
Zhang WQ, Chen HG and Gu LJ: Preoperative lymphocyte count is a
favorable prognostic factor of disease-free survival in
non-small-cell lung cancer. Med Oncol. 30:3522013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang H, Zhang L, Zhu K, Shi B, Yin Y, Zhu
J, Yue D, Zhang B and Wang C: Prognostic significance of
combination of preoperative platelet count and
neutrophil-lymphocyte ratio (COP-NLR) in patients with non-small
cell lung cancer: Based on a large cohort study. PLoS One.
10:e01264962015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McMillan DC: The systemic
inflammation-based Glasgow prognostic score: A decade of experience
in patients with cancer. Cancer Treat Rev. 39:534–540. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu PF, Huang WC, Yang JC, Lu YS, Shih JY,
Wu SG, Lin CH and Cheng AL: Phosphorylated insulin-like growth
factor-1 receptor (pIGF1R) is a poor prognostic factor in brain
metastases from lung adenocarcinomas. J Neurooncol. 115:61–70.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kwon KY, Ro JY, Singhal N, Killen DE,
Sienko A, Allen TC, Zander DS, Barrios R, Haque A and Cagle PT:
MUC4 expression in non-small cell lung carcinomas: Relationship to
tumor histology and patient survival. Arch Pathol Lab Med.
131:593–598. 2007.PubMed/NCBI
|
